EMA
approval
· 2025-12-11
EMA Authorised: Darunavir Viatris (previously Darunavir Mylan) (darunavir) — Viatris Limited
Summary
EMA authorised the darunavir product Darunavir Viatris for HIV infections. This is the generic version of darunavir (formerly marketed as Darunavir Mylan).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: HIV Infections. MAH: Viatris Limited. Decision date: 04/12/2025